Objective: to evaluate the occurrence of polypharmacy and its association with the adherence to the pharmacological treatment in patients with diabetes mellitus type 2. Methods: cross-sectional study conducted with 235 patients with diabetes mellitus type 2 through interview about the demographic and clinical data, drug therapy prescribed and adherence to treatment. To analyze the data, we used Student t-tests and Chi-square, with significance level p<0.05. Results: polypharmacy was evidenced in 88.4% of cases with a predominance of moderate level. An average of 7.5 pills per person among the 19 types of prescribed drugs were used. Adherence to prescribed therapy was reported by 88.2% of patients evaluated and there was no association wi...
Objective: This study was conducted to determine the adherence of medications among type 2 diabetes ...
Background: Evidence in the literature indicates that patients with type 2 diabetes (T2D) have a ve...
The Diabetes Mellitus type 2 (DM2) is an worldwide endocrine disorder. The therapy drug-based aims m...
Background: Diabetes mellitus (DM) is a cluster of metabolic diseases in which a person blood sugar ...
Objective: to evaluate the occurrence of polypharmacy and its association with the adherence to the ...
Background and Aims Non-adherence is considered a major barrier to better outcomes of diabetes care....
Purpose/Aim: Diabetes mellitus is associated with several comorbid conditions. Thus, often, diabetic...
Background: The point of the examination was to assess adherence to treatment and elements related w...
Purpose: To determine whether desirable diabetes control is associated with polypharmacy and to eval...
Background: objective of the study was to evaluate adherence to therapy and factors associated with ...
OBJECTIVE: To evaluate antidiabetic drug treatment patterns and glycemic control among patients diag...
AIM: To describe the prevalence and characteristics of polypharmacy in a Dutch cohort of individuals...
Abstract Patients with diabetes are at high risk for polypharmacy (ie, use of multiple medications) ...
Aim To describe the prevalence and characteristics of polypharmacy in a Dutch cohort of individuals ...
Aim: Polypharmacy in older diabetics can have detrimental effects linked to poor adherence and the r...
Objective: This study was conducted to determine the adherence of medications among type 2 diabetes ...
Background: Evidence in the literature indicates that patients with type 2 diabetes (T2D) have a ve...
The Diabetes Mellitus type 2 (DM2) is an worldwide endocrine disorder. The therapy drug-based aims m...
Background: Diabetes mellitus (DM) is a cluster of metabolic diseases in which a person blood sugar ...
Objective: to evaluate the occurrence of polypharmacy and its association with the adherence to the ...
Background and Aims Non-adherence is considered a major barrier to better outcomes of diabetes care....
Purpose/Aim: Diabetes mellitus is associated with several comorbid conditions. Thus, often, diabetic...
Background: The point of the examination was to assess adherence to treatment and elements related w...
Purpose: To determine whether desirable diabetes control is associated with polypharmacy and to eval...
Background: objective of the study was to evaluate adherence to therapy and factors associated with ...
OBJECTIVE: To evaluate antidiabetic drug treatment patterns and glycemic control among patients diag...
AIM: To describe the prevalence and characteristics of polypharmacy in a Dutch cohort of individuals...
Abstract Patients with diabetes are at high risk for polypharmacy (ie, use of multiple medications) ...
Aim To describe the prevalence and characteristics of polypharmacy in a Dutch cohort of individuals ...
Aim: Polypharmacy in older diabetics can have detrimental effects linked to poor adherence and the r...
Objective: This study was conducted to determine the adherence of medications among type 2 diabetes ...
Background: Evidence in the literature indicates that patients with type 2 diabetes (T2D) have a ve...
The Diabetes Mellitus type 2 (DM2) is an worldwide endocrine disorder. The therapy drug-based aims m...